Spontaneous premature ovarian failure: Management challenges

References

• Rees M, Purdie D. Premature menopause. Management of the menopause: The Handbook. 4th ed. Royal Society of Medicine Press Ltd, London 2006; 142–149
   Google Scholar
• Coulam C B, Adamson S C, Annegers J F. Incidence of premature ovarian failure. Obstet Gynecol 1986; 67: 604–606
   PubMed Web of Science ®Google Scholar
• Rebar R W, Connolly H V. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990; 53: 804–810
   PubMed Web of Science ®Google Scholar
• Nelson L M, Anasti J N, Kimzey L M, Defensor R A, Lipetz K J, White B J, Shawker T H, Merino M J. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994; 79: 1470–1475
   PubMed Web of Science ®Google Scholar
• van Karseren Y M, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999; 5: 483–492
   PubMed Web of Science ®Google Scholar
• Welt C K. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) Oct 29, 2007, [Epub ahead of print]
   Google Scholar
• Popat V B, Vanderhoof V H, Calis K A, Troendle J F, Nelson L M. Normalization of serum luteinizing hormone levels in women with 46,XX spontaneous primary ovarian failure. Fertil Steril 2007; 89: 429–433
   Google Scholar
• Albright F, Smith P, Fraser R. A syndrome characterized by primary ovarian insufficiency and decreased stature. Am J Med Sci 1942; 204: 625–648
   Google Scholar
• Stenchever M A, Droegemueller W, Herbst A L, Mishell D RJ. Primary and secondary amenorrhea. Comprehensive gynecology, M A Stenchever, W Droegemueller, A L Herbst, D RJ Mishell. Mosby, St Louis, MO 2001; 1099–1123
   Google Scholar
• Rebar R W, Connolly H V. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990; 53: 804–810
   PubMed Web of Science ®Google Scholar
• Conway G S, Kaltsas G, Patel A, Davies M C, Jacobs H S. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996; 65: 337–341
   PubMed Web of Science ®Google Scholar
• Chakravati S, Collins W P, Forecast J D, Newton J R, Oram D H, Studd J W. Hormone profile after the menopause. Br Med J 1976; 2: 784–786
   Google Scholar
• Speroff L, Fritz M A. Amenorrhea. Clinical gynecologic endocrinology and infertility7th ed., L Speroff, M A Fritz. Lippincott Williams & Wilkins, Philadelphia, PA 2005; 402–453
   Google Scholar
• Alzubaidi N H, Chapin H L, Vanderhoof V H, Calis K A, Nelson L M. Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol 2002; 99: 720–725
   PubMed Web of Science ®Google Scholar
• Tibiletti M G, Testa G, Vegetti W, Alagna F, Crosignani P G. The idiopathic forms of premature menopause and early menopause show the same genetic pattern. Hum Reprod 1999; 14: 2731–2734
   PubMed Web of Science ®Google Scholar
• Vegetti W, Marozzi A, Manfredini E, Testa G, Alagna F, Nicolosi A, Caliari I, Taborelli M, Tibiletti M, Dalpra L, et al. Premature ovarian failure. Mol Cell Endocrinol 2000; 161: 53–57
   PubMed Web of Science ®Google Scholar
• Rebar R W, Erickson G F, Yen S SC. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 1982; 37: 35–41
   PubMed Web of Science ®Google Scholar
• , et al. Rebar RW, Cedars MI, Hypergonadotropic forms of amenorrhea in young women. Endocrinol Metab Clin North Am 1992; 21: 173–191
   Google Scholar
• Prueitt R, Chen H, Barnes R, Zinn A. Most X autosomes translocations associated with premature ovarian failure do not interrupt X-linked genes. Cytogenet Genome Res 2002; 97: 32–38
   PubMedGoogle Scholar
• Schlessinger D, Herrera L, Crisponi L, Mumm S, Percesepe A, Pellegrini M, Pilia G, Forabosco A. Genes and translocations involved in POF. Am J Med Genet 2002; 111: 328–333
   PubMed Web of Science ®Google Scholar
• Marozzi A, Manfredini E, Tibiletti M G, Furlan D, Villa N, Vegetti W, Crosignani P G, Ginilli E, Meneveri R, Dalpra L. Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum Genet 2000; 107: 304–311
   Google Scholar
• Sherman S L. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 2000; 97: 189–194
   PubMed Web of Science ®Google Scholar
• Marozzi A, Vegetti W, Manfredini E, Tibiletti M G, Crosignani P G, Ginelli E, Meneveri R, Dalprà L. Association between idiopathic premature ovarian failure and fragile X permutation. Hum Reprod 2000; 15: 197–202
   PubMed Web of Science ®Google Scholar
• Welt C K, Smith P C, Taylor A E. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 2004; 89: 4569–4574
   PubMed Web of Science ®Google Scholar
• Nelson L M, Covington S N, Rebar R W. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 2005; 83: 1327–1332
   PubMed Web of Science ®Google Scholar
• Bussani C, Papi L, Sestini R, Baldinotti F, Bucciantint S, Bruni V, Scarselli G. Premature ovarian failure and fragile X premutation: a study on 45 women. Eur J Obstet Gynecol Reprod Biol 2004; 112: 189–191
   PubMedGoogle Scholar
• Bodega B, Bion S, Dalpra L, Toniolo D, Ornaghi F, Vegetti W, Ginelli E, Marozzi A. Influence of intermediate and uninterrupted FMR1 CGC expansions in premature ovarian failure manifestation. Hum Reprod 2006; 21: 952–957
   PubMed Web of Science ®Google Scholar
• Aittomaki K, Lucena J L, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila E, Lehvaslaiho H, Engel A, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995; 82: 959–968
   PubMed Web of Science ®Google Scholar
• Kaufman F R, Kogut M D, Donnell G N, Goebelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981; 17: 994–998
   Google Scholar
• Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney B, Zeesman S, Kaneski C, Schiffmann R, Boespflug-Tanguy O. Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 2003; 72: 1544–1550
   PubMed Web of Science ®Google Scholar
• Criponi L, Deina M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nature Genet 2001; 27: 159–166
   Google Scholar
• Bodega B, Porta C, Crosignani P G, Ginelli E, Marozzi A. Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Mol Hum Reprod 2004; 10: 555–557
   Google Scholar
• Bakalov V K, Vanderhoof V H, Bondy C A, Nelson L M. Adrenal antibodies detect asymptomatic autoimmune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002; 17: 2096–2100
   PubMed Web of Science ®Google Scholar
• Falorni A, Laureti S, Candeloro P, Perrino S, Coronella C, Bizzarro A, Bellastella A, Santeusanio F, De Bellis A. Steroid-cell auto-antibodies are preferentially expressed in women with premature ovarian failure who have adrenal auto-immunity. Fertil Steril 2002; 78: 270–279
   PubMed Web of Science ®Google Scholar
• Wheatcroft N J, Salt C, Milford-Ward A, Cook I D, Weetman A P. Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod 1997; 12: 2617–2622
   Google Scholar
• Ahonen P, Koskimies S, Lokki M L, Tiilikainen A, Perheentupa J. The expression of autoimmune polyglandular disease type 1 appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab 1988; 66: 1152–1157
   PubMed Web of Science ®Google Scholar
• Wheatcroft N, Weetman A P. Is premature ovarian failure an autoimmune disease?. Autoimmunity 1997; 25: 157–165
   PubMed Web of Science ®Google Scholar
• Morrison J C, Givens J R, Wiser W L, Fish S A. Mumps oophritis: a cause for premature menopause. Fertil Steril 1975; 26: 655–659
   PubMed Web of Science ®Google Scholar
• Singer D, Hunter M. Premature menopause: A multi-disciplinary approach. Whurr Publishers Ltd, London 2000
   Google Scholar
• Liao K L, Wood N, Conway G S. Premature menopause and psychological well-being. J Psychosom Obstet Gynaecol 2000; 21: 167–174
   PubMed Web of Science ®Google Scholar
• Petras K. The premature menopause book. Harper Collins Publishers, New York 2002; 110
   Google Scholar
• Kalantaridou S N, Naka K K, Papanikolaoua E, Kazakos N, Kravariti M, Calis K A, Paraskevaidis E A, Sideris D A, Tsatsoulis A, Chrousos G P, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004; 89: 3907–3913
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson J E, Stampfer M J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) 2006; 15: 35–44
   PubMed Web of Science ®Google Scholar
• van Der Voort D J, van Der Weijer P H, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int 2003; 14: 525–530
   PubMed Web of Science ®Google Scholar
• Sherwin B B. Estrogen and cognitive aging in women. Neuroscience 2006; 138: 1021–1026
   PubMed Web of Science ®Google Scholar
• Rapp P R, Morrison J H, Roberts J A. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 2003; 23: 5708–5714
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal result from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Mishell D R, Jr, Nakamura R M, Crosignani P G, Stone S, Kharma K, Nagata Y, Thorneycroft I H. Serum gonadotropins and steroid patterns during the normal menstrual cycle. Am J Obstet Gynecol 1971; 111: 60–65
   PubMed Web of Science ®Google Scholar
• Chetkowski R J, Meldrum D R, Steingold K A, Randle D, Lu J K, Eggena P, Hershman J M, Alkjaersig N K, Fletcher A P, Judd H L. Biologic effects of transdermal estradiol. N Engl J Med 1986; 314: 1615–1620
   PubMed Web of Science ®Google Scholar
• Kanders B S, Lindsay R. The effect of physical activity and calcium intake on the bone density of young women age 24 – 35. Med Sci Sports Exerc 1985; 17: 284
   Web of Science ®Google Scholar